Inventor · disambiguated record
Julian Alexander Barden
Also filed as: BARDEN JULIAN · BARDEN JULIAN ALEXANDER
32 granted patents·13 pending applications·407 citations·filing 2000–2024
97Inventor score
Files withBIOSCEPTRE AUST PTY LTD15BARDEN JULIAN ALEXANDER9BIOSCEPTRE INT LTD6BIOSCEPTRE PTY LTD3GIDLEY-BAIRD ANGUS3
Top patents by PatentIndex Score
45 records- 0196US8080635B2Non-functional P2X7 receptorBARDEN JULIAN ALEXANDER·Filed 2010·Granted Dec 20, 2011·29 cites·2 claims
- 0296US7888473B2Non-functional P2X7 receptorINTREAT PTY LTD·Filed 2009·Granted Feb 15, 2011·33 cites·1 claims
- 0396US7531171B2Antibodies to non-functional P2X7 receptorINTREAT PTY LTD·Filed 2008·Granted May 12, 2009·34 cites·7 claims
- 0495US8399617B2Non-functional P2X7 receptorBARDEN JULIAN ALEXANDER·Filed 2011·Granted Mar 19, 2013·21 cites·1 claims
- 0595US8067550B2Hybridomas producing antibodies against non functional P2X7 receptorBARDEN JULIAN ALEXANDER·Filed 2007·Granted Nov 29, 2011·29 cites·11 claims
- 0694US9127059B2Anti P2X7 receptor antibodies and fragments thereofBARDEN JULIAN ALEXANDER·Filed 2010·Granted Sep 8, 2015·15 cites·6 claims
- 0794US8658385B2Purinergic (P2X) receptors in extra-cellular body fluidGIDLEY-BAIRD ANGUS·Filed 2012·Granted Feb 25, 2014·16 cites·4 claims
- 0894US8597643B2Antibodies for binding to non-functional P2X7 receptors in trimeric formBARDEN JULIAN ALEXANDER·Filed 2009·Granted Dec 3, 2013·18 cites·15 claims
- 0994US8440186B2P2X7 epitopesBARDEN JULIAN ALEXANDER·Filed 2008·Granted May 14, 2013·20 cites·13 claims
- 1094US8293491B2Purinergic (P2X) receptors in extra-cellular body fluidGIDLEY-BAIRD ANGUS·Filed 2008·Granted Oct 23, 2012·26 cites·8 claims
- 1194US7326415B2Antibodies to non-functional P2X7 receptorINTREAT PTY LTD·Filed 2003·Granted Feb 5, 2008·43 cites·26 claims
- 1292US9688771B2Anti P2X7 receptor antibodies and fragments thereofBIOSCEPTRE INT LTD·Filed 2015·Granted Jun 27, 2017·6 cites·15 claims
- 1392US9562094B2Companion animal treatmentsBARDEN JULIAN ALEXANDER·Filed 2011·Granted Feb 7, 2017·8 cites·8 claims
- 1490US9181320B2Peptides for generating an antibody selectively binding to a non-ATP-binding P2X7 receptor but not to an ATP-binding P2X7 receptorBIOSCEPTRE INT LTD·Filed 2013·Granted Nov 10, 2015·11 cites·8 claims
- 1590US8835609B2Antigen binding sites to non-functional oligomeric P2X7 receptors and methods of use thereofBARDEN JULIAN ALEXANDER·Filed 2010·Granted Sep 16, 2014·14 cites·10 claims
- 1689US12097265B2Cytotoxic particles for targeting P2X7 receptorBIOSCEPTRE AUST PTY LTD·Filed 2022·Granted Sep 24, 2024·1 cites·19 claims
- 1789US9328155B2Peptides for inducing antibodies to a non-functional P2X7 receptorBIOSCEPTRE INT LTD·Filed 2013·Granted May 3, 2016·9 cites·2 claims
- 1889US2025084161A1Anti p2x7 receptor antibodies and fragments thereofBIOSCEPTRE AUST PTY LTD·Filed 2024·Application pending·0 cites
- 1988US10053508B2Anti P2X7 receptor antibodies and fragments thereofBIOSCEPTRE AUST PTY LTD·Filed 2017·Granted Aug 21, 2018·5 cites·15 claims
- 2088US9663584B2Antibodies to non-functional P2X7 receptorBIOSCEPTRE INT LTD·Filed 2015·Granted May 30, 2017·4 cites·8 claims
- 2188US7183064B1Method for identifying pre-neoplastic and/or neoplastic states in mammalsBIOSCEPTRE PTY LTD·Filed 2000·Granted Feb 27, 2007·39 cites·4 claims
- 2287US10988532B2Anti P2X7 receptor antibodies and fragments thereofBIOSCEPTRE AUST PTY LTD·Filed 2018·Granted Apr 27, 2021·2 cites·16 claims
- 2387US9566318B2Combination therapyBARDEN JULIAN ALEXANDER·Filed 2012·Granted Feb 14, 2017·8 cites·9 claims
- 2485US11260131B2Cytotoxic particles for targeting P2X7 receptorBIOSCEPTRE AUST PTY LTD·Filed 2017·Granted Mar 1, 2022·2 cites·14 claims
- 2585US10245308B2Combination therapy utilizing P2X7 peptidesBIOSCEPTRE AUST PTY LTD·Filed 2017·Granted Apr 2, 2019·4 cites·9 claims
- 2683US10238716B2Anti-P2X7 peptides and epitopesBIOSCEPTRE AUST PTY LTD·Filed 2016·Granted Mar 26, 2019·3 cites·3 claims
- 2783US10232025B2Method for minimising progression of cancer in companion animalsBIOSCEPTRE AUST PTY LTD·Filed 2016·Granted Mar 19, 2019·3 cites·10 claims
- 2879US9428587B2Antibodies to non-functional oligomeric P2X7 receptors and methods of use thereofBIOSCEPTRE INT LTD·Filed 2014·Granted Aug 30, 2016·3 cites·13 claims
- 2976US12129295B2Anti P2X7 receptor antibodies and fragments thereofBIOSCEPTRE AUST PTY LTD·Filed 2021·Granted Oct 29, 2024·0 cites·16 claims
- 3072US2020071419A1Antibodies to non-functional p2x7 receptorBIOSCEPTRE AUST PTY LTD·Filed 2019·Application pending·0 cites
- 3169US9944701B2Methods of treating cancer with antibodies that bind P2X7 receptorsBIOSCEPTRE INTERNATIONAL LTD·Filed 2015·Granted Apr 17, 2018·1 cites·12 claims
- 3267US10450380B2Polypeptide immunogen for generating an antibody to non-functional P2X7 receptorBIOSCEPTRE AUST PTY LTD·Filed 2017·Granted Oct 22, 2019·0 cites·7 claims
- 3366US2014323693A1Antibodies To Non-Functional P2X7 ReceptorBIOSCEPTRE INT LTD·Filed 2014·Application pending·0 cites
- 3465US2024376193A1Novel dysfunctional p2x7 bindersSCHLEGEL PATRICK·Filed 2022·Application pending·0 cites
- 3564US10597451B2Methods of treating cancer with a P2X7 peptideBIOSCEPTRE AUST PTY LTD·Filed 2018·Granted Mar 24, 2020·0 cites·12 claims
- 3662US10543262B2Combination therapy utilizing P2X7 peptidesBIOSCEPTRE AUST PTY LTD·Filed 2019·Granted Jan 28, 2020·0 cites·9 claims
- 3760US2025282844A1Methods for controlling immune cell activityBIOSCEPTRE AUST PTY LTD·Filed 2022·Application pending·0 cites
- 3860US2025281611A1Novel cell therapy systemBIOSCEPTRE AUST PTY LTD·Filed 2022·Application pending·0 cites
- 3954US2007248963A1method for identifying pre-neoplastic and/or neoplastic states in mammalsSLATER MICHAEL·Filed 2006·Application pending·0 cites
- 4054US2008227122A1P2y purinergic receptor expression for identifying preneoplastic and neoplastic statesBIOSCEPTRE PTY LTD·Filed 2008·Application pending·0 cites
- 4151US2011111431A1Method for identifying pre-neoplastic and/or neoplastic states in mammalsBIOSCEPTRE PTY LTD·Filed 2010·Application pending·0 cites
- 4248US2010036101A1Antibodies against non functional p2x7 receptorGIDLEY-BAIRD ANGUS·Filed 2007·Application pending·0 cites
- 4346US2004067542A1P2y purinergic receptor expression for identifying preneoplastic and neoplastic statesFiled 2001·Application pending·0 cites
- 4440US2004067967A1Treatment of urinary dysfunctionFiled 2001·Application pending·0 cites
- 4538US2018037650A1Pain TreatmentBIOSCEPTRE UK LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Julian Alexander Barden files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →